Probenecid

CAS No. 57-66-9

Probenecid( NSC 18786 )

Catalog No. M15105 CAS No. 57-66-9

The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 34 In Stock
1G 47 In Stock

Biological Information

  • Product Name
    Probenecid
  • Note
    Research use only, not for human use.
  • Brief Description
    The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.
  • Description
    The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 18786
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRPV2
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    57-66-9
  • Formula Weight
    285.36
  • Molecular Formula
    C13H19NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 22 mg/mL (77.09 mM); DMSO: 57 mg/mL (199.74 mM)
  • SMILES
    CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
  • Chemical Name
    4-(dipropylsulfamoyl)benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.McDonough PM, et al. Cell Calcium, 1989, 10(3), 171-180.
molnova catalog
related products
  • Pyr3

    Pyr3 is a selective transient receptor potential canonical channel 3 inhibitor. Pyr3 inhibits TRPC3-mediated Ca2+ influx in a dose-dependent manner(IC50 = 700 nM).

  • TC-I2000

    TC-I2000 is an TRPM8 channel blocker. Inhibits?icilin-induced TRPM8 channel activation in rTRPM8-expressing CHO cells with IC50?of 53 nM.

  • Pinokalant

    Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region.